LexDanaLexDanabeta
Inventor

FABIAN KIESSLING

Inventor
DE

Overview

2→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
11,951,166Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer202411,517,622Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to BAYER AG (2)· patent assignee history
2022Patents assigned to BAYER HEALTHCARE LLC (1)· patent assignee history
2022–2024Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAYER AG22022–2024
BAYER HEALTHCARE LLC12022
Locations
LocationPatentsSpan
DE22022–2024